ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $16,881 | -14.2% | 15,487 | 0.0% | 0.00% | -20.0% |
Q1 2024 | $19,668 | -8.6% | 15,487 | 0.0% | 0.01% | -16.7% |
Q4 2023 | $21,527 | -0.7% | 15,487 | 0.0% | 0.01% | -14.3% |
Q3 2023 | $21,682 | -23.9% | 15,487 | 0.0% | 0.01% | -22.2% |
Q2 2023 | $28,496 | -24.3% | 15,487 | 0.0% | 0.01% | -25.0% |
Q1 2023 | $37,633 | +69.9% | 15,487 | 0.0% | 0.01% | +71.4% |
Q4 2022 | $22,146 | -36.7% | 15,487 | 0.0% | 0.01% | -41.7% |
Q3 2022 | $35,000 | – | 15,487 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 1,047,732 | $5,333,000 | 2.30% |
KOPP INVESTMENT ADVISORS LLC | 232,099 | $1,181,000 | 1.17% |
GLOBEFLEX CAPITAL L P | 225,834 | $1,149,000 | 0.29% |
KEMPNER CAPITAL MANAGEMENT INC. | 70,001 | $356,000 | 0.24% |
Breithorn Capital Management | 63,324 | $322,000 | 0.24% |
Acrospire Investment Management LLC | 55,444 | $282,000 | 0.19% |
EAM Investors, LLC | 267,368 | $1,361,000 | 0.18% |
Granahan Investment Management | 875,002 | $4,454,000 | 0.15% |
Geduld E E | 15,000 | $76,000 | 0.08% |
GILDER GAGNON HOWE & CO LLC | 872,009 | $4,439,000 | 0.08% |